Volume 6, 2002 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance
Jones Marty
|
Jan/Feb 2002
Pg. 4-6
|
Compounding with Controlled Substances
Whalen Mary Kate
|
Jan/Feb 2002
Pg. 8-10
|
The Problem of Drug Diversion
Burke John J
|
Jan/Feb 2002
Pg. 11-12
|
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective
Vail Jane
|
Jan/Feb 2002
Pg. 13-15
|
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Vail Jane
|
Jan/Feb 2002
Pg. 16-18
|
Benzocaine 2% Sorbitol Antigag Candy
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 17
|
Tetracycline 5%, Dexamethasone 0.2% Periodontal Gel
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 17
|
Fluoride 0.25-mg Sugar-Free Hard Candy
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 17
|
Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity
Foy Elizabeth, MacCara Mary E
|
Jan/Feb 2002
Pg. 19-21
|
Creating a Productivity Measurement Tool for a Home Infusion Pharmacy
Chamallas Stanley N
|
Jan/Feb 2002
Pg. 24-26
|
Team Building For Success
King Dean J
|
Jan/Feb 2002
Pg. 27-30
|
Technology Spotlight: Capsule-Filling Machines
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 31
|
Compounding in History: Dental Considerations
Worthen Dennis B
|
Jan/Feb 2002
Pg. 32-33
|
Basics of Compounding Biotechnologic Preparations
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 34-37
|
Analgesic NSAID Suppositories
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 40
|
Capsaicin 0.075% Topical Spray
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 41
|
Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 42
|
Diltiazem HCl 2% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 43
|
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 44
|
Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 45
|
Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 46
|
Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 47
|
Morphine Sulfate 5-mg/0.1-mL Nasal Spray
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 48
|
Oxycodone 25-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 49
|
Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Wepfer Scott T
|
Jan/Feb 2002
Pg. 50-54
|
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Kastango Eric S, Hadaway Lynn
|
Jan/Feb 2002
Pg. 55-57
|
Poloxamers, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 58-59
|
Safety for Employees in the Compounding Work Area
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 60-61
|
Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes
Trissel Lawrence A, Xu Quanyun A, Pham Lien
|
Jan/Feb 2002
Pg. 62-65
|
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes
Xu Quanyun A, Trissel Lawrence A, Pham Lien
|
Jan/Feb 2002
Pg. 66-69
|
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes
Trissel Lawrence A, Xu Quanyun A, Pham Lien
|
Jan/Feb 2002
Pg. 70-73
|
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes
Trissel Lawrence A, Xu Quanyun A, Pham Lien
|
Jan/Feb 2002
Pg. 74-76
|
Calculations
Prince Shelly J
|
Jan/Feb 2002
Pg. 77
|
Toothpowder
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 33
|
Liquid Dentifrice
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 33
|
Toothache Wax
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 33
|
PostScription: Regulatory Uncertainty Requires Professional Responsibility
King LD
|
Jan/Feb 2002
Pg. 80
|
Compounding for Skin Care: An Interview with John Hollis, RPh
Vail Jane
|
Mar/Apr 2002
Pg. 85-86
|
Mary Kay Inc: Compounding in a Cosmetics Megacorporation
Vail Jane
|
Mar/Apr 2002
Pg. 88-91
|
Hair Styling Gel Formula-Example Formulation
Vail Jane
|
Mar/Apr 2002
Pg. 90
|
Skin Moisturizer Formula
Vail Jane
|
Mar/Apr 2002
Pg. 91
|
Cream Formulation (Oil-in-Water Emulsion)
Vail Jane
|
Mar/Apr 2002
Pg. 91
|
Options in Wound Care
Kincaid Michele R
|
Mar/Apr 2002
Pg. 92-95
|
Dermatologic and Cosmetic Lines from Compounding Pharmacies in Brazil
Fonseca Simonne C, Ferreira Anderson de O
|
Mar/Apr 2002
Pg. 96-97
|
Excerpts from and Reviews of Current Published Literature: Treating Dermatologic Conditions
Foy Elizabeth, MacCara Mary E
|
Mar/Apr 2002
Pg. 98-100
|
Book Review: The Wrinkle Cure
Reed-Kane Dana
|
Mar/Apr 2002
Pg. 101
|
Basics of Compounding: Cosmetics for Special Populations and Using Cosmetics as Vehicles
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 102-105
|
Lotion
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 103
|
Dusting Powder
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 103
|
Hand Cream
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 103
|
Stick Formulation
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 104
|
Hard-Stick Formulation
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 104
|
Soft-Stick Formulation (Clear Stick Base)
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 104
|
Blemish-Hiding Stick
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 104
|
Clear Shampoo
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 104
|
Cream Shampoo
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 104
|
Liquid Deoderant and/or Antiperspirant
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 105
|
Shaving Cream (Brushless)
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 105
|
Shaving Cream (Brushless)
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 105
|
Astringent Mouthwash
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 105
|
Developing a Successful Compounding Business in a Small Town
Svoboda Angie
|
Mar/Apr 2002
Pg. 108-110
|
A Guide to Effective Media Relations
Walker Jennifer Klein
|
Mar/Apr 2002
Pg. 111-112
|
Technology Spotlight: Waring Blenders
Rains Joe, Casalino Larry
|
Mar/Apr 2002
Pg. 114
|
Wish You Were Here: The History of Pharmacy Museum at the Arizona College of Pharmacy, Tucson, Arizona
Worthen Dennis B
|
Mar/Apr 2002
Pg. 116-117
|
Tablet Cutting
Sam Kendra
|
Mar/Apr 2002
Pg. 118-119
|
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
|
Mar/Apr 2002
Pg. 120-122
|
Medications Discontinued in the United States
Ashworth Lisa D
|
Mar/Apr 2002
Pg. 123
|
Antipruritic Gel
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 126
|
Cold Sore Ointment
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 127
|
Glycolic Acid 15% Gel
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 128
|
Halobetasol and Calcipotriene Cream
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 129
|
Medicated Aftershave Lotion
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 130
|
Metronidazole 1% Topical Spray
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 131
|
Mycophenolate Mofetil 2% Topical Cream
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 132
|
Tranilast 0.8% for Iontophoresis
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 133
|
Tranilast Topical 2% Penetrating Mixture
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 134
|
Wart Remover Mixture
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 135
|
Veterinary Compounding for Ferrets
Miller Cari E
|
Mar/Apr 2002
Pg. 136-139
|
Sterilization of Talc for Use in Pleurodesis
Fehr Richard, Henke Michelle, Ashworth Lisa D
|
Mar/Apr 2002
Pg. 140-141
|
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
|
Mar/Apr 2002
Pg. 142-146
|
Polysorbates, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 147-148
|
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory
Ashworth Lisa D, Gordon Dana, Leiter Charles W, Snow Whit
|
Mar/Apr 2002
Pg. 149-150
|
Deodorant Stick
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 105
|
Calculations
Prince Shelly J
|
Mar/Apr 2002
Pg. 151
|
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Xu Quanyun A, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S
|
Mar/Apr 2002
Pg. 152-154
|
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
|
Mar/Apr 2002
Pg. 155-157
|
PostScription-Ensuring Compounding Excellence: Quality Control or Quality Assurance?
Kupiec Thomas C
|
Mar/Apr 2002
Pg. 160
|
Healthful Living: Good Practices for Good Health
Jackson Kathy
|
May/Jun 2002
Pg. 164-166
|
Compounding for Geriatrics Patients
Armstrong Eldon
|
May/Jun 2002
Pg. 168-170
|
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
|
May/Jun 2002
Pg. 171-176
|
Lollipops: The Evolution of a Dosage Form
Mason Dave, Fields Shannon
|
May/Jun 2002
Pg. 178-179
|
Book Reviews: Wellness, Nutrition and Geriatrics
Reed-Kane Dana, Ashworth Lisa D
|
May/Jun 2002
Pg. 180-181
|
Compounding in History: The Road to Wellville
Worthen Dennis B
|
May/Jun 2002
Pg. 184-185
|
How To Perform a Study in Your Pharmacy with Little or No Effort
Reed-Kane Dana
|
May/Jun 2002
Pg. 186-187
|
Technology Spotlight: Electric Mixing Machines
Schneider Gary
|
May/Jun 2002
Pg. 188
|
Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam
Vetter Eric R, Curtis Lawrence
|
May/Jun 2002
Pg. 189-192
|
Medications Discontinued in the United States
Ashworth Lisa D
|
May/Jun 2002
Pg. 193
|
Basics of Compounding: Iontophoresis, Part 1
Allen Loyd V Jr
|
May/Jun 2002
Pg. 194-197
|
Anhydrous Emollient Dry Skin Lotion
Allen Loyd V Jr
|
May/Jun 2002
Pg. 199
|
Antiseptic Protective Ointment
Allen Loyd V Jr
|
May/Jun 2002
Pg. 200
|
Camphor, Menthol, and Eucalyptol Rubefacient Ointment
Allen Loyd V Jr
|
May/Jun 2002
Pg. 201
|
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2002
Pg. 202
|
Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO
Allen Loyd V Jr
|
May/Jun 2002
Pg. 203
|
Misoprostol 0.0024%, Metronidazole 2%, and Pentoxifyline 5% Decubitus Ulcer Cream
Allen Loyd V Jr
|
May/Jun 2002
Pg. 204
|
Nicotine 2-mg Lollipops
Allen Loyd V Jr
|
May/Jun 2002
Pg. 205
|
Nicotine Medication Stick
Allen Loyd V Jr
|
May/Jun 2002
Pg. 206
|
Podophyllum, Lactic Acid, and Salicylic Acid Wart Mixture
Allen Loyd V Jr
|
May/Jun 2002
Pg. 207
|
Vitamin B12 1-mg/mL Nasal Spray
Allen Loyd V Jr
|
May/Jun 2002
Pg. 208
|
The Treatment of Canine Atopic Disease
Davidson Gigi S
|
May/Jun 2002
Pg. 210-215
|
pH and Osmolarity, A Review of
Stranz Marc, Kastango Eric S
|
May/Jun 2002
Pg. 216-220
|
Sorbitan Esters, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2002
Pg. 221-223
|
Developing Standard Operating Procedures
Allen Loyd V Jr
|
May/Jun 2002
Pg. 224-225
|
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping, Trissel Lawrence A
|
May/Jun 2002
Pg. 226-229
|
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P
|
May/Jun 2002
Pg. 230-233
|
Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
|
May/Jun 2002
Pg. 234-236
|
Calculations
Prince Shelly J
|
May/Jun 2002
Pg. 237
|
PostScription: Building Relationships with Special Patient Populations
Angelle Patsy
|
May/Jun 2002
Pg. 240
|
Mild Laxative
Worthen Dennis B
|
May/Jun 2002
Pg. 185
|
Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel
Worthen Dennis B
|
May/Jun 2002
Pg. 185
|
A Review of Current Research on the Effects of Progesterone
Boomsma Diane, Jim Paoletti
|
Jul/Aug 2002
Pg. 245-249
|
The Hormonal Link to Breast Cancer: The Estrogen Matrix
Zava David T
|
Jul/Aug 2002
Pg. 250-254
|
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
|
Jul/Aug 2002
Pg. 255-256
|
Establishing an Andropause Practice
Biundo Bruce
|
Jul/Aug 2002
Pg. 259-261
|
Compounding and the Courts
Gibbs Jeffrey N, Wasserstein Jeffrey N
|
Jul/Aug 2002
Pg. 263-266
|
Facilities and Procedures for Compounding Hazardous Drugs
Rahe Hank
|
Jul/Aug 2002
Pg. 267-270
|
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Kramer Mark A, Grilley Bambi J
|
Jul/Aug 2002
Pg. 271-273
|
Legal Issues: Technicians in the Compounding Pharmacy Practice
Fix Jennifer Taylor
|
Jul/Aug 2002
Pg. 274-275
|
Excerpts from and Reviews of Current Published Literature: Pharmacy Administration and Other Topics of Interest
Foy Elizabeth, MacCara Mary E
|
Jul/Aug 2002
Pg. 278-280
|
Magnetic Iron “Whiskers” in Cereals
Newton David W, Hoffman Tovah G
|
Jul/Aug 2002
Pg. 281-283
|
Wish You Were Here: Chicago, Illinois
Worthen Dennis B
|
Jul/Aug 2002
Pg. 284-285
|
Medications Discontinued in the United States
Ashworth Lisa D
|
Jul/Aug 2002
Pg. 286-287
|
Basics of Compounding for Iontophoresis, Part II
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 288-292
|
Lidocaine HCl 4% Solution for Iontophoresis
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 290
|
Dexamethasone 4-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 290
|
Acetic Acid 2% Solution for Iontophoresis
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 290
|
Ketorolac 6-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 291
|
Dehydroepiandrosterone 25-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 293
|
Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 294
|
Estradiol 0.5-mg Sublingual Troches
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 295
|
Estradiol 1-mg/0.1-mL Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 296
|
Estradiol 1-mg/0.1-g Topical Cream
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 297
|
Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 298
|
Estriol 2-mg/mL Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 299
|
Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 300
|
Testosterone 25-mg in Oil Capsules
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 301
|
Testosterone 50-mg/mL Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 302
|
Topical Oil-in-Water Cream Bases, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 303-304
|
Calculations
Prince Shelly J
|
Jul/Aug 2002
Pg. 305
|
Standard Operaing Procedure for the Quality Assessment of Nasal Solutions
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 306-307
|
Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Stewart James T, Storms Meredith L, Warren Flynn W
|
Jul/Aug 2002
Pg. 308-310
|
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A, Saenz Christopher
|
Jul/Aug 2002
Pg. 311-315
|
Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
|
Jul/Aug 2002
Pg. 316-317
|
PostScription: Certification: Now Is the Time
Bertin Richard J
|
Jul/Aug 2002
Pg. 320
|
Navigating New Territories in Compounding for Veterinary Medicine
Davidson Gigi S
|
Sep/Oct 2002
Pg. 324-327
|
Total Parenteral Nutrition for Animals
Sammarco Domenic A
|
Sep/Oct 2002
Pg. 328-330
|
Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson Gigi S
|
Sep/Oct 2002
Pg. 332-336
|
Rites of Passage
Downing Robin
|
Sep/Oct 2002
Pg. 337
|
Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
|
Sep/Oct 2002
Pg. 338-343
|
Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism
Wingate Gary
|
Sep/Oct 2002
Pg. 344-345
|
Excerpts from and Reviews of Current Published Literature: Veterinary Topics
Foy Elizabeth, MacCara Mary E
|
Sep/Oct 2002
Pg. 346-347
|
Veterinary Book Reviews
Reed-Kane Dana
|
Sep/Oct 2002
Pg. 349
|
Compounding in History: Equine Health
Worthen Dennis B
|
Sep/Oct 2002
Pg. 350-351
|
Quality in Pharmacy: The New Zealand Experience
Hamilton Pauline
|
Sep/Oct 2002
Pg. 354-358
|
Third-Party Contracting for Compounding Pharmacies
Heckman H Edward
|
Sep/Oct 2002
Pg. 359-361
|
Basics of Compounding: Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 362-365
|
Ultrasound Gels-Carbopol Type
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 363
|
Ultrasound Gels-Hydoxyethyl Cellulose Type
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 363
|
Betamethasone Dipropionate 0.05% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Piroxicam 0.5% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Dexamethasone Sodium 0.4% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Fluocinonide 0.1% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Ketoprofen 2% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Naproxen 5% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Sodium Salicylate 10% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Hydrocortisone 10% Gel for Phonophoresis
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 364
|
Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 365
|
Zinc Oxide 20% Gel
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 365
|
Iodine and Methylsalicylate Ultrasound Ointment
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 365
|
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 367
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 368
|
Oral Liquid Vehicle for Equine Use
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 369
|
Phenytoin Topical Powder
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 370
|
Tetracycline and Hydrocortisone Otic Suspension
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 371
|
Veterinary Carminative
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 372
|
Oral Liquid for Diarrhea
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 373
|
Veterinary Penicillamine 20-mg/mL Oral Liquid, Avian
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 374
|
Veterinary Thrush Formula, Equine
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 375
|
Veterinary Topical Anesthetic and Astringent Gel
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 376
|
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy
Santoro Filippo
|
Sep/Oct 2002
Pg. 378
|
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix
Timmons Evelyn D, Timmons Steven P
|
Sep/Oct 2002
Pg. 379
|
Featured Excipient: Specially Denatured Alcohols
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 380-383
|
Collecting Laboratory and Other Clinical Efficacy Data on Veterinary Patients
Davidson Gigi S, Ashworth Lisa D
|
Sep/Oct 2002
Pg. 384-385
|
Calculations
Prince Shelly J
|
Sep/Oct 2002
Pg. 387
|
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L, Stewart James T, Warren Flynn W
|
Sep/Oct 2002
Pg. 388-390
|
Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags
Schlesser Vincent, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
|
Sep/Oct 2002
Pg. 391-394
|
Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes
Gupta Vishnu D
|
Sep/Oct 2002
Pg. 395-397
|
PostScription: Exec. VP & CEO NCPA
Roberts Bruce T
|
Sep/Oct 2002
Pg. 400
|
Spavin Treatment
Worthen Dennis B
|
Sep/Oct 2002
Pg. 351
|
Cough Ball (Veterinary)
Worthen Dennis B
|
Sep/Oct 2002
Pg. 351
|
Horse Liniment
Worthen Dennis B
|
Sep/Oct 2002
Pg. 351
|
The Cost of Quality in Pharmacy
Kastango Eric S
|
Nov/Dec 2002
Pg. 404-407
View Sample |
Comparison of Endotoxin Testing Methods for Pharmaceutical Products
Joiner Timothy J, Kraus Paul F, Kupiec Thomas C
|
Nov/Dec 2002
Pg. 408-409
View Sample |
Phenytoin Injections: From Compounding to Cerebyx
Newton David W
|
Nov/Dec 2002
Pg. 410-413
|
Book Review: Sterile Compounding
Reed-Kane Dana
|
Nov/Dec 2002
Pg. 414
|
Sterile Compounding of Respiratory Inhalation Solutions
Roberts Rob, Moore Eddie
|
Nov/Dec 2002
Pg. 415-417
|
Pediatric Dermatitis
Remmert Renee
|
Nov/Dec 2002
Pg. 419-421
|
Excerpts from and Reviews of Current Published Literature: Pediatric Medications
Foy Elizabeth, MacCara Mary E
|
Nov/Dec 2002
Pg. 423
|
Book Reviews: Compounding for Pediatric Patients
Ashworth Lisa D, Reed-Kane Dana
|
Nov/Dec 2002
Pg. 424-425
|
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1
Chamallas Stanley N, Sullivan Kathleen
|
Nov/Dec 2002
Pg. 428-432
|
Regulatory and Operational Issues of Founding a Compounding Pharmacy
Smith Lisa K
|
Nov/Dec 2002
Pg. 434-437
|
Technology Spotlight: Liquid-Filling Machines
Braverman Bob, Northcutt Kyle
|
Nov/Dec 2002
Pg. 439-440
|
Medications Discontinued in the United States
Ashworth Lisa D
|
Nov/Dec 2002
Pg. 441-442
|
Basics of Compounding: Clinical Studies
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 443-447
|
Benzalkonium Chloride 1:750 Solution for Cold Disinfection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 448
|
Caffeine and Sodium Benzoate 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 449
|
Dexamethasone Sodium Phosphate 4-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 450
|
Dimenhydrinate 50-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 451
|
Erythromycin and Dexamethasone Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 452
|
Furosemide 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 453
|
Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 454
|
Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 455
|
Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 456
|
Phenobarbital Sodium 130-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 457
|
Andropause: A Review of Treatment Options
Jonathan Bamarom H
|
Nov/Dec 2002
Pg. 458-461
|
Featured Excipient: Disinfecting Agents
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 462-464
|
Calculations
Prince Shelly J
|
Nov/Dec 2002
Pg. 465
|
Cleaning and Disinfection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 466-467
|
Chemical Stability of Furosemide in Minibags and Polypropylene Syringes
Donnelly Ronald F
|
Nov/Dec 2002
Pg. 468-470
|
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L, Stewart James T, Warren Flynn W
|
Nov/Dec 2002
Pg. 475-477
|
PostScription: The Times They Are A-Changin
Leake Mike
|
Nov/Dec 2002
Pg. 480
|
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L, Kokki H, Rasi A S, Naaranlahti Toivo J
|
Nov/Dec 2002
Pg. 471-474
|
Return to Top |